- Home
- NRO vs STXS Comparison
NRO vs STXS Comparison
Compare NRO & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- STXS
- Stock Information
- Founded
- NRO 2003
- STXS 1990
- Country
- NRO United States
- STXS United States
- Employees
- NRO N/A
- STXS N/A
- Industry
- NRO Finance/Investors Services
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NRO Finance
- STXS Health Care
- Exchange
- NRO Nasdaq
- STXS Nasdaq
- Market Cap
- NRO 156.7M
- STXS 151.3M
- IPO Year
- NRO N/A
- STXS 2004
- Fundamental
- Price
- NRO $3.20
- STXS $2.17
- Analyst Decision
- NRO
- STXS
- Analyst Count
- NRO 0
- STXS 0
- Target Price
- NRO N/A
- STXS N/A
- AVG Volume (30 Days)
- NRO 239.4K
- STXS 270.0K
- Earning Date
- NRO 01-01-0001
- STXS 08-11-2025
- Dividend Yield
- NRO 11.41%
- STXS N/A
- EPS Growth
- NRO N/A
- STXS N/A
- EPS
- NRO N/A
- STXS N/A
- Revenue
- NRO N/A
- STXS $27,510,000.00
- Revenue This Year
- NRO N/A
- STXS $25.90
- Revenue Next Year
- NRO N/A
- STXS $60.57
- P/E Ratio
- NRO N/A
- STXS N/A
- Revenue Growth
- NRO N/A
- STXS 1.50
- 52 Week Low
- NRO $2.51
- STXS $1.54
- 52 Week High
- NRO $3.45
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- NRO 51.58
- STXS 52.27
- Support Level
- NRO $3.17
- STXS $2.00
- Resistance Level
- NRO $3.27
- STXS $2.36
- Average True Range (ATR)
- NRO 0.04
- STXS 0.11
- MACD
- NRO -0.00
- STXS -0.01
- Stochastic Oscillator
- NRO 58.33
- STXS 50.00
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.